Changes in Beneficial Ownership · 4
Sana Biotechnology, Inc.
SANANASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
primarydocument.xml
Filing details
- Report period
- 2026-06-04
- Issuer
- Sana Biotechnology, Inc.
- Issuer CIK
- 0001770121
- Trading symbol
- SANA
Reporting owner 1
- Name
- Rosiello Robert L.
- Reporting owner CIK
- 0001645041
- Relationship
- Director
- Address
- C/O SANA BIOTECHNOLOGY, INC., 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA, 98102
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 2.96 | 2026-06-04 | A · Form 4 | 90,000.00 | A | 0.00 | [F1] | 2036-06-03 | Common Stock | 90,000.00 | 90,000.00 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.↩ 1
Remarks
Exhibit List: Ex. 24 - Power of Attorney
Signature 1
- Signed
- /s/ Aaron M. Grossman, Attorney-in-Fact for Robert L. Rosiello
- Date
- 2026-06-05
Filed exhibits
- ROSIELLO POA ↗rosiellopoax.txt
Company context
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are a passionate group of people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA.